118 related articles for article (PubMed ID: 8301154)
1. Consensus interferon induces peak mRNA accumulation at lower concentrations than interferon-alpha 2a.
Klein SB; Blatt LM; Taylor MW
J Interferon Res; 1993 Oct; 13(5):341-7. PubMed ID: 8301154
[TBL] [Abstract][Full Text] [Related]
2. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
[TBL] [Abstract][Full Text] [Related]
4. Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist.
Huang Y; Blatt LM; Taylor MW
J Interferon Cytokine Res; 1995 Apr; 15(4):317-21. PubMed ID: 7627806
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
Dhib-Jalbut S; Jiang H; Xia Q; Blatt L; Johnson KP; Hilt D
J Interferon Cytokine Res; 1996 Mar; 16(3):195-200. PubMed ID: 8697141
[TBL] [Abstract][Full Text] [Related]
6. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
Ozes ON; Klein SB; Reiter Z; Taylor MW
Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional model of a human interferon-alpha consensus sequence.
Korn AP; Rose DR; Fish EN
J Interferon Res; 1994 Feb; 14(1):1-9. PubMed ID: 7517984
[TBL] [Abstract][Full Text] [Related]
8. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
9. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
10. An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferon.
Cotler SJ; Reddy KR; McCone J; Wolfe DL; Liu A; Craft TR; Ferris MW; Conrad AJ; Albrecht J; Morrissey M; Ganger DR; Rosenblate H; Blatt LM; Jensen DM; Taylor MW
J Interferon Cytokine Res; 2001 Dec; 21(12):1011-9. PubMed ID: 11798458
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional models of interferon-alpha subtypes IFN-con1, IFN-alpha8, andIFN-alpha1 derived from the crystal structure of IFN-alpha2b.
Walter MR
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-52-S9-62. PubMed ID: 9208873
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of interferon-gamma and -alpha 2a to tumor cells and their antitumor activities.
Ishii Y; Tsukagoshi S
J Pharmacobiodyn; 1988 Jul; 11(7):465-71. PubMed ID: 3141606
[TBL] [Abstract][Full Text] [Related]
13. The synergistic effect of human recombinant interferon-alpha 2a in combination with interferon-gamma and the induction of interferon-alpha 2a receptor by interferon-gamma.
Ishii Y; Tsukagoshi S
J Pharmacobiodyn; 1989 May; 12(5):299-304. PubMed ID: 2530332
[TBL] [Abstract][Full Text] [Related]
14. Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice.
D'Agostino G; Aricò E; Santodonato L; Venditti M; Sestili P; Masuelli L; Coletti A; Modesti A; Picchio G; Mosier DE; Ferrantini M; Belardelli F
J Interferon Cytokine Res; 1999 Nov; 19(11):1305-16. PubMed ID: 10574624
[TBL] [Abstract][Full Text] [Related]
15. The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon.
Blatt LM; Davis JM; Klein SB; Taylor MW
J Interferon Cytokine Res; 1996 Jul; 16(7):489-99. PubMed ID: 8836913
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression.
Zhang JF; Hu C; Geng Y; Blatt LM; Taylor MW
Cancer Gene Ther; 1996; 3(1):31-8. PubMed ID: 8785709
[TBL] [Abstract][Full Text] [Related]
17. Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA.
Moore M; Meager A; Wadhwa M; Burns C
J Pharm Biomed Anal; 2009 Feb; 49(2):534-9. PubMed ID: 19097723
[TBL] [Abstract][Full Text] [Related]
18. Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.
Brideau-Andersen AD; Huang X; Sun SC; Chen TT; Stark D; Sas IJ; Zadik L; Dawes GN; Guptill DR; McCord R; Govindarajan S; Roy A; Yang S; Gao J; Chen YH; Skartved NJ; Pedersen AK; Lin D; Locher CP; Rebbapragada I; Jensen AD; Bass SH; Nissen TL; Viswanathan S; Foster GR; Symons JA; Patten PA
Proc Natl Acad Sci U S A; 2007 May; 104(20):8269-74. PubMed ID: 17494769
[TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-dihydroxy vitamin D3 modulation of HLA-DR mRNA induced by gamma-interferon in cultured epithelial tumor cell lines.
Tone T; Eto H; Katou T; Otani F; Nishiyama S
J Dermatol; 1993 Sep; 20(9):581-4. PubMed ID: 8227716
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human acute promyelocytic leukemia NB-4 cells by interferons and all-trans retinoic acid: trans-modulation of inducible gene expression pathways.
Kumar R; Korutla L
Anticancer Res; 1995; 15(2):353-60. PubMed ID: 7763006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
